Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation

Annals of Hematology

Volumn 91, Issue 8, 2012, Pages 1305-1312

  Taniguchi, Kyoko ^a   Yoshihara, Satoshi ^a   Tamaki, Hiroya ^a   Fujimoto, Tsuguto ^b   Ikegame, Kazuhiro ^a   Kaida, Katsuji ^a   Nakata, Jun ^a   Inoue, Takayuki ^a   Kato, Ruri ^a   Fujioka, Tatsuya ^a   Okada, Masaya ^a   Soma, Toshihiro ^a   Ogawa, Hiroyasu ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Adenovirus infection; Cidofovir; Donor lymphocyte infusion; Haploidentical transplantation; Hemorrhagic cystitis

Indexed keywords

CIDOFOVIR; CREATININE; GANCICLOVIR; IMMUNOGLOBULIN; VIRUS DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADENOVIRUS; ADENOVIRUS GROUP B; ADENOVIRUS INFECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS ANTIGENEMIA; CYTOMEGALOVIRUS INFECTION; DISSEMINATED ADENOVIRUS INFECTION; DONOR LYMPHOCYTE INFUSION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HAPLOIDENTICAL STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; HYDRONEPHROSIS; INCIDENCE; LARGE CELL LYMPHOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONHUMAN; PATIENT MONITORING; POSTRENAL OBSTRUCTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROTYPE; SEX DIFFERENCE; STEM CELL TRANSPLANTATION; T CELL LEUKEMIA; URINARY TRACT OBSTRUCTION; VIRUS DETECTION; VIRUS PNEUMONIA;

ADENOVIRUS INFECTIONS, HUMAN; ADOLESCENT; ADULT; AGED; FEMALE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; VIRAL LOAD; YOUNG ADULT;

EID: 84865023157     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1440-3     Document Type: Article

References (36)

1. Tomblyn M, Chiller T, Einsele H et al (2009) Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant 44:453-558
2. Veltrop-Duits LA, van Vreeswijk T, Heemskerk B et al (2011) High titers of pre-existing adenovirus serotype-specific neutralizing antibodies in the host predict viral reactivation after allogeneic stem cell transplantation in children. Clin Infect Dis 52:1405-1413
3. Howard DS, Phillips IG, Reece DE et al (1999) Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 29:1494-1501 (Pubitemid 30022747)
4. Lion T, Baumgartinger R, Watzinger F et al (2003) Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102:1114-1120 (Pubitemid 36917814)
5. Robin M, Marque-Juillet S, Scieux C et al (2007) Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome. Haematologica 92:1254-1257 (Pubitemid 350144187)
6. Heemskerk B, Lankester AC, van Vreeswijk T et al (2005) Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J Infect Dis 191:520-530 (Pubitemid 40216667)
7. Chakrabarti S, Mautner V, Osman H et al (2002) Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 100:1619-1627 (Pubitemid 34925137)
8. Myers GD, Krance RA, Weiss H et al (2005) Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplant 36:1001-1008 (Pubitemid 41741564)
9. Kampmann B, Cubitt D, Walls T et al (2005) Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 130:595-603 (Pubitemid 43899764)
10. Munoz-Cobo B, Solano C, Nieto J, et al. (2011) Surveillance for adenovirus DNAemia early after transplantation in adult recipients of unrelated-donor allogeneic stem cell transplants in the absence of clinically suspected infection. Bone Marrow Transplant 46:1484-1486
11. de Pagter AP, Haveman LM, Schuurman R, Schutten M, Bierings M, Boelens JJ (2009) Adenovirus DNA positivity in nasopharyngeal aspirate preceding hematopoietic stem cell transplantation: a very strong risk factor for adenovirus DNAemia in pediatric patients. Clin Infect Dis 49:1536-1539
12. Lindemans CA, Leen AM, Boelens JJ (2010) How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood 116:5476-5485
13. Hromas R, Cornetta K, Srour E, Blanke C, Broun ER (1994) Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 84:1689-1690 (Pubitemid 24273046)
14. Chakrabarti S, Collingham KE, Fegan CD, Pillay D, Milligan DW (2000) Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? Bone Marrow Transplant 26:305-307 (Pubitemid 30614411)
15. Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A (2001) Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 32:1290-1297 (Pubitemid 32405900)
16. Feuchtinger T, Matthes-Martin S, Richard C et al (2006) Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 134:64-76 (Pubitemid 43830030)
17. Leen AM, Christin A, Myers GD et al (2009) Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood 114:4283-4292
18. Ogawa H, Ikegame K, Yoshihara S et al (2006) Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biol Blood Marrow Transplant 12:1073-1084
19. Ogawa H, Ikegame K, Kaida K et al (2008) Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. Exp Hematol 36:1-8 (Pubitemid 350266965)
20. Teramura T, Naya M, Yoshihara T, Kanoh G, Morimoto A, Imashuku S (2004) Adenoviral infection in hematopoietic stem cell transplantation: early diagnosis with quantitative detection of the viral genome in serum and urine. Bone Marrow Transplant 33:87-92 (Pubitemid 38159709)
21. Takeuchi S, Itoh N, Uchio E, Aoki K, Ohno S (1999) Serotyping of adenoviruses on conjunctival scrapings by PCR and sequence analysis. J Clin Microbiol 37:1839-1845 (Pubitemid 29235233)
22. Przepiorka D, Weisdorf D, Martin P et al (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15:825-828
23. Shulman HM, Sullivan KM, Weiden PL et al (1980) Chronic graftversus- host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69:204-217 (Pubitemid 10036817)
24. Hoffman JA, Shah AJ, Ross LA, Kapoor N (2001) Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7:388-394 (Pubitemid 32799057)
25. Nagafuji K, Aoki K, Henzan H et al (2004) Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 34:909-914 (Pubitemid 39562142)
26. Savona MR, Newton D, Frame D, Levine JE, Mineishi S, Kaul DR (2007) Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant 39:783-787 (Pubitemid 46901977)
27. Flomenberg P, Babbitt J, Drobyski WR et al (1994) Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 169:775-781 (Pubitemid 24102109)
28. Akiyama H, Kurosu T, Sakashita C et al (2001) Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 32:1325-1330 (Pubitemid 32405905)
29. Asano Y, Kanda Y, Ogawa N et al (2003) Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 32:1175-1179 (Pubitemid 38072331)
30. Mufson MA, Belshe RB (1976) A review of adenoviruses in the etiology of acute hemorrhagic cystitis. J Urol 115:191-194
31. Schilham MW, Claas EC, van Zaane Wet al (2002) High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin Infect Dis 35:526-532
32. Gustafson I, Lindblom A, Yun Z et al (2008) Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients. J Clin Virol 43:79-85
33. Ohrmalm L, Lindblom A, Omar H et al (2011) Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome. Bone Marrow Transplant 46:267-272
34. Yoshihara S, Kato R, Inoue T et al (2004) Successful treatment of life-threatening human herpesvirus-6 encephalitis with donor lymphocyte infusion in a patient who had undergone human leukocyte antigen-haploidentical nonmyeloablative stem cell transplantation. Transplantation 77:835-838 (Pubitemid 38436819)
35. Kawakami M, Nakata J, Ohguro N et al (2005) A case of immune recovery vitritis induced by donor leukocyte infusion for the treatment of cytomegalovirus retinitis. Eur J Haematol 75:352-354 (Pubitemid 41297613)
36. Heemskerk B, Veltrop-Duits LA, van Vreeswijk T et al (2003) Extensive cross-reactivity of CD4+ adenovirus-specific Tcells: implications for immunotherapy and gene therapy. J Virol 77:6562-6566 (Pubitemid 36588428)